|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.310 USD | -2.00% |
|
-7.97% | -7.28% |
| 06-29 | Xilio Therapeutics, Inc.(NasdaqCM:XLO) added to Russell Microcap Value Benchmark Index | CI |
| 06-29 | Xilio Therapeutics, Inc. Announces Appointment of Ben Harshbarger as Chief Legal Officer | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Neutral |
| Resistance | 9.58 | 9.58 | 11.45 |
| Spread/Res. | -13.26% | -13.26% | -27.44% |
| Spread/Supp. | +0.73% | +0.73% | +16.36% |
| Support | 8.25 | 8.25 | 7.141 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- XLO Stock
- Charts Xilio Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
